Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
磷酸化RPA2可预测同源重组功能正常的卵巢癌对铂类和PARP抑制剂的反应
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI189511
Schab Angela, Compadre Amanda, Drexler Rebecca, Loeb Megan, Rodriguez Kevin, Brill Joshua, Harrington Shariska, Sandoval Carmen, Sanders Brooke, Kuroki Lindsay, McCourt Carolyn, Hagemann Andrea R, Thaker Premal, Mutch David, Powell Matthew, Serra Violeta, Hagemann Ian S, Walts Ann E, Karlan Beth Y, Orsulic Sandra, Fuh Katherine C, Sun Lulu, Verma Priyanka, Lomonosova Elena, Zhao Peinan, Khabele Dineo, Mullen Mary M